Chloral hydrate
Information sheet
This substance was identified for action under the Chemicals Management Plan (CMP).
| CAS RN | Common name | DSL name | Public comments on the draft screening assessment | Final screening assessment | Conclusion on section 64 criteria | Follow-up activities |
|---|---|---|---|---|---|---|
302-17-0 |
1,1-Ethanediol, 2,2,2-trichloro- |
Does not meet |
Information gathering |
Follow-up activities
While exposure of the general population to chloral hydrate is not of concern at current levels, this substance is considered to have a health effect of concern on the basis of its potential carcinogenicity. Therefore, there may be a concern for human health if exposures were to increase. Follow-up activities will involve including the substance in future information gathering initiatives, such as a mandatory survey under section 71 of the Canadian Environmental Protection Act, 1999 (CEPA 1999). Stakeholders will be given advance notice of any planned information gathering.
Information gathering
Section 71 CMP 2023
In June 2023, a notice was published in the Canada Gazette, Part I: Vol. 157, No. 25 – June 24, 2023 under section 71 of CEPA 1999. This notice applies to chloral hydrate (CAS RN 302-17-0). More information is available on the Information gathering with respect to certain substances under the Chemicals Management Plan web page.
| Date | Activity |
|---|---|
| June 24, 2023 | Publication in Canada Gazette, Part I, of a notice under section 71 of CEPA 1999. |
October 7, 2017 |
Publication of the final screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 151, No. 40. |
December 17, 2016 |
Publication and start of 60-day public comment period on the draft screening assessment (including follow-up activities). The related notice was published in the Canada Gazette, Part I: Vol. 150, No. 51. |
Page details
- Date modified: